IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population

QR Code

IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population

Inducible degrader of the low density lipoprotein receptor (IDOL), is an E3 ubiquitin ligase that negatively modulates low density lipoprotein receptor (LDL-R) expression. Genome-wide association studies (GWAS) indicated that genetic variants in IDOL gene contributes to variation in LDL-C plasma lev...

Full description

Bibliographic Details
Main Authors:	Dhyani, A., Tibolla, G., Baragetti, A., Garlaschelli, K., Pellegatta, F., Grigore, L., Norata, Giuseppe, Catapano, A.
Format:	Journal Article
Published:	Public Library of Science 2015
Online Access:	http://hdl.handle.net/20.500.11937/55788

Similar Items

Genetically determined telomeres shortening is associated with carotid atherosclerosis progression and increased incidence of cardiovascular events
by: Baragetti, A., et al.
Published: (2016)

Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)

Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population
by: Baragetti, A., et al.
Published: (2016)

Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population
by: Baragetti, A., et al.
Published: (2015)

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

-374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease
by: Baragetti, I., et al.
Published: (2013)

High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)

The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)

Effector memory T cells are associated with atherosclerosis in humans and animal models
by: Ammirati, E., et al.
Published: (2012)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up
by: Fracanzani, A., et al.
Published: (2016)

Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population
by: Baragetti, A., et al.
Published: (2014)

Pentraxins and atherosclerosis
by: Barbati, E., et al.
Published: (2014)

Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)

MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice
by: Sala, F., et al.
Published: (2014)

Disease trends over time and CD4+CCR5+ T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus
by: Baragetti, A., et al.
Published: (2017)

Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis
by: Ammirati, E., et al.
Published: (2015)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
by: Baragetti, A., et al.
Published: (2017)

Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse
by: Norata, Giuseppe, et al.
Published: (2012)

Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease
by: Fracanzani, A., et al.
Published: (2016)

Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia
by: Grigore, L., et al.
Published: (2013)

Idolizing “My Love from the Star”: Idol attachment and fanaticism of luxury brands
by: Cheah, Isaac, et al.
Published: (2018)

Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014)

Gene silencing approaches for the management of dyslipidaemia
by: Norata, Giuseppe, et al.
Published: (2013)

Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)

PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
by: Norata, Giuseppe, et al.
Published: (2014)

Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus
by: Ammirati, E., et al.
Published: (2014)

Virtual idol and youth identity: the impact of mainstream culture on the virtual idol online fanbase community in China
by: Song, Liuyan, et al.
Published: (2024)

Trained immunity and cardiovascular disease: Is it time for translation to humans?
by: Norata, Giuseppe
Published: (2018)

Idol Attachment and Human Brand Loyalty
by: Huang, Y., et al.
Published: (2015)

The Idol Audience: Judging, Interactivity and Entertainment
by: Stratton, Jon
Published: (2008)

Nazirah juara putra Idol UPM
by: Utusan Malaysia,
Published: (2013)

HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l1n8r0de0an2e672suv9m0l85u